Stories

On what inspired him to become a scientist.

​

On what made Jim a successful scientist.

Research associate on her experience working in Jim's lab.

Cancer survivor on her road to leading a healthy life.

Texas Monthly journalist on Jim’s unique scientific process and the importance of basic science.

Parker Institute CEO on how far cancer immunology has come and his hopes for the field.

MD Anderson scientist on his father's illness inspiring him to study immunology.

Former BMS scientific director on Jim’s impact on the ipi team.

Clinician on the immunotherapy and playing music with Jim.

On his experience studying cancer and why the immune system is critical to curing cancer.

On Jim using science to avoid the draft.

Shares his experience working on Ipilimumab and immunotherapy drugs.

On his experience working in Jim's lab at Berkeley.

On his relationship with Jim and being outsiders in the world of cancer research.

NYU Professor on scientific communities around the world.

Genetech VP of Cancer Immunology on the history and prospects of immunotherapy.

On the evolution of cancer treatments.

UC Berkeley colleague on being recruited by Jim and working on the frontiers of immunology.

On the evolution of the immune system and why cancer is so difficult to beat.

On coming to America and falling in love with science.

Former BMS executive on the difficulties developing ipilimumab.

Nobel laureate and former Memorial Sloan Kettering President on recruiting Jim.

Oncologist on Jim's impact on improving melanoma life expectancy.

Discusses Ipi, its challenges, and meeting a patient.